IO360° brings together science, clinical and business under one roof to accelerate treatments to fight a wider range of cancers. This brief podcast gives you an overview on what you can expect at IO360°.

The three-day summit features 10 plenary sessions with over 80 speakers and includes ten plus hours of networking. There will be over 450 attendees.

Key benefits:

Access to KOLs driving the science
Partnership opportunities with all stakeholders in Immuno-Oncology
Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

IO360° is chaired by Dr Andrew Baum, Citi along with Dr Axel Hoos, GlaxoSmithKline and Dr James Gulley, National Cancer Institute.

Learn more information about IO360° at www.io360summit.com

Take 10% off the regitration fee with code RADIO

5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect

Share

Embed